Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Targeting TGFβ can improve skin immunity in older people.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Skin issues can indicate immune system problems.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Somatostatin may help protect hair follicles from immune attacks.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

CD2 might be a new treatment target for patchy alopecia areata.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.